Description
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
AZ-5104 is an active metabolite of AZD-9291 (osimertinib), an inhibitor of EGFR. It has shown efficacy in models of non-small cell lung cancer.
| Cas No. | 1421373-98-9 |
|---|---|
| Purity | ≥98% |
| Formula | C27H31N7O2 |
| Formula Wt. | 485.59 |
| IUPAC Name | N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-5-{[4-(1H-indol-3-yl)-2-pyrimidinyl]amino}-4-methoxyphenyl)acrylamide |
| Synonym | AZ-5104, AZ 5104, AZ5104 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Yates J. Ashton S., et al. Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104. Mol Cancer Ther. 15(10):2378-87 (2016). PMID: 27439477.
Ethisterone derivative, synthetic steroid, used...
Calcium channel blocker.
EGFR inhibitor.
c-MET and Ron inhibitor.
Synthetic isoflavone.
Aromatase inhibitor.
Sesquiterpene alkaloid found in Huperzia serrat...
Triazole; gibberellin inhibitor, potential 14-Î...
Curcumin derivative; DNMT1 and α-amylase inhib...
Tyrphostin; IGF-1R inhibitor.
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
Diarylether; bacterial ENR binder, fatty acid s...
mTOR inhibitor.
Geldanamycin derivative; HSP90 inhibitor.
PI3K and mTOR inhibitor.
p110β PI3K inhibitor.
Synthetic steroid; glucocorticoid agonist.
Iron chelator.
Natriuretic, vasodilatory peptide fragment; B1/...
Synthetic nitrile compound